69P Combining sintilimab with anlotinib as second-line or later therapy in patients with extensive-disease small cell lung cancer: A prospective, single-arm, phase II trial
Titel:
69P Combining sintilimab with anlotinib as second-line or later therapy in patients with extensive-disease small cell lung cancer: A prospective, single-arm, phase II trial
Auteur:
Shuxiang, M. Zhen, H. Lili, W. Yufeng, W. Sen, Y. Haiyang, C. Yingxi, W. Wang, Q.